Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 448, 121 (12 July 2007) | doi:10.1038/448121a; Published online 11 July 2007
Open Innovation Challenges
-
Methods to Analyze Consumer Emotions
The Seeker is looking for methods to analyze consumer emotions. This Challenge requires only a writ...
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
nature jobs
Postdoctoral Fellow - Computational Genomics - Team 78 – Ref: 80464
- Wellcome Trust Sanger Institute
- Hinxton, Cambridgeshire CB10 1, UK
REDD Land-use Change Modeller
- The Macaulay Institute
- Aberdeen, AB15 8QH, UK
In brief
Abbott Laboratories, the Illinois-based drug company, reached agreement with the Brazilian government to sell its AIDS drug Kaletra there for a reduced price — lifting the threat that Brazil might license it compulsorily. On 4 July, the company said it would sell it there for $1,000 per patient per year, down by about 30%.
To read this story in full you will need to login or make a payment (see right).

